Login to Your Account

International Biotechnology Trust Reports Strong Investor Returns

By Nuala Moran
Staff Writer

Monday, October 22, 2012

LONDON – International Biotechnology Trust (IBT) reported strong returns for shareholders, driven by new drug approvals, high levels of merger and acquisition activity and the resilience of leading biotech companies in the current growth-stunting environment.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription